A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

NCT06282159 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG: DNTH103
DRUG: Placebo

Sponsor

Dianthus Therapeutics